Clinical Trial Update: Evaluation of Refractive Outcomes in Patients Undergoing PRESBYOND Using the MEL90 Excimer Laser

View source ↗

Summary

Clinical trial update evaluating refractive outcomes in presbyopia patients undergoing PRESBYOND with the MEL90 excimer laser; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Snippet

Sponsor: Carl Zeiss Meditec AG | Conditions: Presbyopia | Status: NOT_YET_RECRUITING